Ensign Group (ENSG) Director Files Form 3 Reporting Shares, Options and RSAs
Rhea-AI Filing Summary
Uychiat Pison Marivic filed an Initial Statement of Beneficial Ownership for The Ensign Group, Inc. (ENSG) reporting direct ownership of 12,963 common shares and multiple employee stock options and restricted stock awards. Reported derivative holdings include options exercisable from 08/26/2020 through 11/06/2025 covering 17,559 shares in aggregate under various exercise prices, and unvested RSAs totaling 2,040 shares subject to five-year vesting schedules.
Positive
- Director alignment: Reporting person holds a combination of common shares, RSAs, and options which aligns interests with shareholders
- Transparent disclosure: Initial Form 3 provides clear detail on amounts, grant dates, vesting schedules, and exercise prices
Negative
- None.
Insights
TL;DR: Routine director filing showing equity ownership and multi-year vesting, aligning director incentives with shareholders.
The Form 3 documents initial disclosure of a director-level reporting person with a mix of vested common shares, vested and unvested restricted stock awards, and several employee stock options spanning 2020 to 2025 grant dates with expirations through 2034. The equity mix and staggered vesting indicate standard alignment incentives; there is no indication of unusual compensation terms or immediate dilution beyond normal option exercises.
TL;DR: Disclosure is informational and non-material to valuation by itself; it confirms insider alignment but not a material transaction.
The filing lists direct ownership of 12,963 shares and option rights to acquire an additional 17,559 shares under multiple grants with exercise prices ranging from $43.59 to $143. The presence of unvested RSAs (2,040 shares) and multi-year vesting schedules is typical for executive/director compensation and does not by itself signal a material change to share count or control.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Includes: 1) 160 unvested Restricted Stock Awards ("RSAs") from an award of 800 RSAs granted February 19, 2021; 2) 400 unvested RSAs from an award of 1,000 RSAs granted February 18, 2022; 3) 480 unvested RSAs from an award of 800 RSAs granted May 18, 2023; and 4) 1,000 unvested RSAs from an award of 1,000 RSAs granted November 6, 2024. RSA shares vest in five equal installments beginning on the first anniversary of the grant date. These shares were granted August 26, 2019 and vested over 5 equal annual installments. These shares were granted August 27, 2020 and vested over 5 equal annual installments. These shares were granted February 19, 2021 and vest over 5 equal annual installments. These shares were granted February 18, 2022 and vest over 5 equal annual installments. These shares were granted May 18, 2023 and vest over 5 equal annual installments. These shares were granted November 2, 2023 and vest over 5 equal annual installments. These shares were granted November 6, 2024 and vest over 5 equal annual installments.
